TY - JOUR
T1 - Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease
AU - Nobili, Valerio
AU - Alisi, Anna
AU - Torre, Giuliano
AU - De Vito, Rita
AU - Pietrobattista, Andrea
AU - Morino, Giuseppe
AU - De Ville De Goyet, Jean
AU - Bedogni, Giorgio
AU - Pinzani, Massimo
PY - 2010
Y1 - 2010
N2 - Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and adolescents, and it may progress to liver fibrosis and cirrhosis. Liver biopsy, which is the recognized gold standard for the diagnosis of hepatic fibrosis, is invasive. Thus, there has been increasing interest in the development of noninvasive markers. Hyaluronic acid (HA) has been shown to be a good marker of liver fibrosis in adults. In the current study, we evaluated the association of HA with liver fibrosis in 100 consecutive children with biopsy-proven NAFLD. In all, 65% of the children had liver fibrosis. Using proportional-odds ordinal logistic regression, we found that values of HA ≥ 1200 ng/mL made the absence of fibrosis (F0) unlikely (7%, 95% confidence interval [CI]: 1% to 14%), whereas values of HA ≥ 2100 ng/mL made F2, F3, or F4 fibrosis likely (89%, 95% CI: 75% to 100%). Our study shows that HA is a predictor of fibrosis in children with NAFLD followed at a tertiary care center. Additional studies are needed to test whether HA can be employed to predict liver fibrosis in pediatric populations with similar and lower prevalence of liver fibrosis.
AB - Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and adolescents, and it may progress to liver fibrosis and cirrhosis. Liver biopsy, which is the recognized gold standard for the diagnosis of hepatic fibrosis, is invasive. Thus, there has been increasing interest in the development of noninvasive markers. Hyaluronic acid (HA) has been shown to be a good marker of liver fibrosis in adults. In the current study, we evaluated the association of HA with liver fibrosis in 100 consecutive children with biopsy-proven NAFLD. In all, 65% of the children had liver fibrosis. Using proportional-odds ordinal logistic regression, we found that values of HA ≥ 1200 ng/mL made the absence of fibrosis (F0) unlikely (7%, 95% confidence interval [CI]: 1% to 14%), whereas values of HA ≥ 2100 ng/mL made F2, F3, or F4 fibrosis likely (89%, 95% CI: 75% to 100%). Our study shows that HA is a predictor of fibrosis in children with NAFLD followed at a tertiary care center. Additional studies are needed to test whether HA can be employed to predict liver fibrosis in pediatric populations with similar and lower prevalence of liver fibrosis.
UR - http://www.scopus.com/inward/record.url?scp=77957309026&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957309026&partnerID=8YFLogxK
U2 - 10.1016/j.trsl.2010.05.008
DO - 10.1016/j.trsl.2010.05.008
M3 - Article
C2 - 20875899
AN - SCOPUS:77957309026
VL - 156
SP - 229
EP - 234
JO - Translational Research
JF - Translational Research
SN - 1931-5244
IS - 4
ER -